Glaukos (GKOS) Earnings Date & Reports

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

GKOS is expected to report earnings to rise 18.61% to -21 cents per share on July 29

Q2'26

Est.

$-0.21

Q1'26

Beat

by $0.10

Q4'25

Missed

by $0.69

Q3'25

Beat

by $0.10

Q2'25

Beat

by $0.02

The last earnings report on April 29 showed earnings per share of -18 cents, beating the estimate of -28 cents. With 727.53K shares outstanding, the current market capitalization sits at 8.92B.

View a ticker or compare two or three

GKOS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days